Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dopamine Plasma Membrane Transport Proteins | 22 | 2013 | 415 | 2.570 |
Why?
|
Membrane Transport Proteins | 17 | 2011 | 1035 | 1.740 |
Why?
|
Membrane Glycoproteins | 14 | 2005 | 3701 | 0.980 |
Why?
|
Dopamine | 18 | 2011 | 1603 | 0.950 |
Why?
|
Cocaine | 11 | 2014 | 958 | 0.870 |
Why?
|
Nerve Tissue Proteins | 13 | 2010 | 4413 | 0.740 |
Why?
|
Coxiella burnetii | 5 | 1999 | 37 | 0.660 |
Why?
|
Minisatellite Repeats | 3 | 2013 | 164 | 0.600 |
Why?
|
Vesicular Monoamine Transport Proteins | 4 | 2011 | 32 | 0.450 |
Why?
|
Dopamine Uptake Inhibitors | 5 | 2005 | 297 | 0.420 |
Why?
|
Promoter Regions, Genetic | 6 | 2013 | 5778 | 0.410 |
Why?
|
Plasmids | 5 | 1999 | 2274 | 0.390 |
Why?
|
Ventral Tegmental Area | 2 | 2011 | 136 | 0.370 |
Why?
|
Rotenone | 4 | 2011 | 45 | 0.370 |
Why?
|
Cerebrospinal Fluid | 1 | 2014 | 544 | 0.370 |
Why?
|
Gene Expression Regulation | 5 | 2013 | 11900 | 0.370 |
Why?
|
Amino Acid Substitution | 7 | 2005 | 1737 | 0.350 |
Why?
|
Norepinephrine Plasma Membrane Transport Proteins | 2 | 2006 | 66 | 0.330 |
Why?
|
Introns | 1 | 2011 | 981 | 0.320 |
Why?
|
Cocaine-Related Disorders | 1 | 2011 | 461 | 0.300 |
Why?
|
Proline | 3 | 2005 | 457 | 0.300 |
Why?
|
Mutagenesis, Site-Directed | 6 | 2005 | 1693 | 0.300 |
Why?
|
Selection, Genetic | 2 | 2010 | 870 | 0.290 |
Why?
|
COS Cells | 9 | 2006 | 1128 | 0.290 |
Why?
|
Alcoholism | 2 | 2010 | 1972 | 0.280 |
Why?
|
Haplotypes | 6 | 2013 | 2773 | 0.280 |
Why?
|
Genetic Variation | 5 | 2011 | 6570 | 0.280 |
Why?
|
Parkinsonian Disorders | 4 | 2011 | 284 | 0.280 |
Why?
|
Carrier Proteins | 6 | 2004 | 4936 | 0.260 |
Why?
|
Receptor, Serotonin, 5-HT2B | 1 | 2004 | 6 | 0.250 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 2 | 2006 | 324 | 0.240 |
Why?
|
Central Nervous System Stimulants | 1 | 2013 | 1176 | 0.240 |
Why?
|
Open Reading Frames | 4 | 2003 | 815 | 0.240 |
Why?
|
Parkinson Disease | 3 | 2013 | 2875 | 0.230 |
Why?
|
Genes, Bacterial | 2 | 1997 | 1079 | 0.210 |
Why?
|
Protein Kinase C | 2 | 2004 | 1202 | 0.190 |
Why?
|
Immunity, Innate | 1 | 2014 | 3059 | 0.190 |
Why?
|
Bacterial Proteins | 6 | 1999 | 3842 | 0.190 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 2 | 2003 | 641 | 0.190 |
Why?
|
RNA, Messenger | 3 | 2016 | 12785 | 0.190 |
Why?
|
Molecular Sequence Data | 12 | 2011 | 17639 | 0.180 |
Why?
|
Tritium | 6 | 2003 | 707 | 0.170 |
Why?
|
Alanine | 5 | 2003 | 606 | 0.170 |
Why?
|
F Factor | 1 | 1998 | 12 | 0.160 |
Why?
|
Staphylococcal Protein A | 1 | 1998 | 39 | 0.160 |
Why?
|
Operon | 2 | 1999 | 374 | 0.150 |
Why?
|
DNA, Bacterial | 3 | 1999 | 1481 | 0.150 |
Why?
|
Phenylalanine | 1 | 1999 | 366 | 0.150 |
Why?
|
Amino Acid Sequence | 10 | 2006 | 13445 | 0.150 |
Why?
|
Cell Line | 6 | 2013 | 15598 | 0.140 |
Why?
|
Structure-Activity Relationship | 4 | 2011 | 3075 | 0.130 |
Why?
|
Gene Frequency | 4 | 2013 | 3637 | 0.130 |
Why?
|
Replication Origin | 1 | 1995 | 77 | 0.130 |
Why?
|
Mesenchymal Stem Cell Transplantation | 2 | 2010 | 499 | 0.120 |
Why?
|
Receptors, Dopamine D2 | 2 | 2016 | 485 | 0.120 |
Why?
|
Binding, Competitive | 3 | 2002 | 1141 | 0.120 |
Why?
|
Signal Transduction | 3 | 2014 | 23397 | 0.120 |
Why?
|
Base Sequence | 6 | 2011 | 12449 | 0.120 |
Why?
|
Chromosomes, Bacterial | 1 | 1995 | 281 | 0.120 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2013 | 15867 | 0.120 |
Why?
|
Mental Disorders | 1 | 2014 | 6831 | 0.110 |
Why?
|
Brain | 6 | 2014 | 27060 | 0.110 |
Why?
|
Animals | 30 | 2014 | 168253 | 0.110 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2003 | 2423 | 0.110 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2003 | 2860 | 0.110 |
Why?
|
Mutagenesis, Insertional | 2 | 2011 | 656 | 0.100 |
Why?
|
Trans-Activators | 3 | 1999 | 2858 | 0.100 |
Why?
|
Umbilical Cord | 2 | 2010 | 179 | 0.100 |
Why?
|
Genetic Markers | 2 | 2011 | 2612 | 0.100 |
Why?
|
Cannabinoids | 2 | 2006 | 172 | 0.100 |
Why?
|
Base Pairing | 1 | 2011 | 140 | 0.100 |
Why?
|
Antipyrine | 1 | 2011 | 40 | 0.100 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2011 | 293 | 0.090 |
Why?
|
Simian virus 40 | 1 | 2011 | 291 | 0.090 |
Why?
|
Escherichia coli | 3 | 1998 | 4234 | 0.090 |
Why?
|
Prosencephalon | 1 | 2013 | 305 | 0.090 |
Why?
|
Control Groups | 1 | 2010 | 104 | 0.090 |
Why?
|
Benzofurans | 1 | 2011 | 139 | 0.090 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2011 | 786 | 0.090 |
Why?
|
Otx Transcription Factors | 1 | 2010 | 42 | 0.090 |
Why?
|
Free Radical Scavengers | 1 | 2011 | 211 | 0.090 |
Why?
|
Chlorpromazine | 1 | 2010 | 111 | 0.090 |
Why?
|
Antiparkinson Agents | 1 | 2011 | 184 | 0.090 |
Why?
|
Radioligand Assay | 2 | 2000 | 366 | 0.090 |
Why?
|
Basal Ganglia Diseases | 1 | 2010 | 145 | 0.080 |
Why?
|
Mesenchymal Stem Cells | 2 | 2010 | 1636 | 0.080 |
Why?
|
Codon | 2 | 2004 | 602 | 0.080 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2013 | 790 | 0.080 |
Why?
|
1-Methyl-4-phenylpyridinium | 2 | 2010 | 34 | 0.080 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2010 | 748 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 4567 | 0.080 |
Why?
|
Polymorphism, Genetic | 3 | 2010 | 4287 | 0.080 |
Why?
|
Polymerase Chain Reaction | 3 | 2011 | 6086 | 0.080 |
Why?
|
3' Untranslated Regions | 1 | 2010 | 515 | 0.080 |
Why?
|
Mesencephalon | 1 | 2010 | 332 | 0.080 |
Why?
|
Vesicular Biogenic Amine Transport Proteins | 2 | 2005 | 9 | 0.080 |
Why?
|
Substance-Related Disorders | 1 | 2004 | 4416 | 0.080 |
Why?
|
Behavior | 1 | 2011 | 540 | 0.070 |
Why?
|
Rats | 11 | 2011 | 23712 | 0.070 |
Why?
|
DNA, Complementary | 1 | 2011 | 1992 | 0.070 |
Why?
|
Alleles | 2 | 2011 | 6908 | 0.070 |
Why?
|
Genetic Association Studies | 2 | 2013 | 2723 | 0.070 |
Why?
|
Clozapine | 1 | 2010 | 506 | 0.070 |
Why?
|
Sequence Homology, Amino Acid | 3 | 1995 | 2749 | 0.070 |
Why?
|
Linkage Disequilibrium | 1 | 2011 | 2004 | 0.070 |
Why?
|
Down-Regulation | 2 | 2011 | 2911 | 0.070 |
Why?
|
Transfection | 4 | 2002 | 5776 | 0.060 |
Why?
|
Tyramine | 1 | 2005 | 53 | 0.060 |
Why?
|
Gene Expression | 3 | 2011 | 7582 | 0.060 |
Why?
|
Protein Binding | 2 | 2011 | 9340 | 0.060 |
Why?
|
Exons | 1 | 2011 | 2392 | 0.060 |
Why?
|
Gene Transfer Techniques | 1 | 2010 | 1205 | 0.060 |
Why?
|
Protein Conformation | 4 | 2000 | 3969 | 0.060 |
Why?
|
DNA Primers | 2 | 2003 | 2820 | 0.060 |
Why?
|
Psychoses, Substance-Induced | 1 | 2006 | 99 | 0.060 |
Why?
|
Mutagenesis | 2 | 1999 | 1233 | 0.060 |
Why?
|
Mutation | 4 | 2003 | 30025 | 0.060 |
Why?
|
Neurons | 4 | 2011 | 9443 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2010 | 10759 | 0.060 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2016 | 1857 | 0.060 |
Why?
|
Biological Transport | 4 | 2004 | 2090 | 0.060 |
Why?
|
Humans | 27 | 2016 | 760437 | 0.060 |
Why?
|
Thermodynamics | 1 | 2005 | 595 | 0.060 |
Why?
|
Protein Phosphatase 1 | 1 | 2004 | 134 | 0.050 |
Why?
|
LLC-PK1 Cells | 1 | 2003 | 125 | 0.050 |
Why?
|
Immunohistochemistry | 3 | 2003 | 11070 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 4 | 2004 | 3734 | 0.050 |
Why?
|
MAP Kinase Kinase 2 | 1 | 2003 | 92 | 0.050 |
Why?
|
Digestive System | 1 | 2004 | 244 | 0.050 |
Why?
|
Analysis of Variance | 1 | 2011 | 6230 | 0.050 |
Why?
|
Mazindol | 1 | 2002 | 13 | 0.050 |
Why?
|
Microsatellite Repeats | 1 | 2004 | 785 | 0.050 |
Why?
|
Genes, Reporter | 2 | 2013 | 1528 | 0.050 |
Why?
|
Mice | 8 | 2014 | 81402 | 0.050 |
Why?
|
Axons | 1 | 2010 | 1673 | 0.050 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2004 | 329 | 0.050 |
Why?
|
Receptors, Drug | 1 | 2002 | 157 | 0.050 |
Why?
|
Brain Chemistry | 2 | 2003 | 959 | 0.050 |
Why?
|
Molecular Motor Proteins | 1 | 2002 | 105 | 0.050 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2004 | 483 | 0.050 |
Why?
|
Sequence Alignment | 1 | 2006 | 2180 | 0.050 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2003 | 331 | 0.050 |
Why?
|
Glycine | 1 | 2004 | 665 | 0.050 |
Why?
|
Gene Expression Regulation, Bacterial | 2 | 1999 | 1133 | 0.050 |
Why?
|
Valine | 1 | 2003 | 408 | 0.050 |
Why?
|
Opioid-Related Disorders | 1 | 2016 | 2152 | 0.050 |
Why?
|
Models, Molecular | 3 | 2000 | 5427 | 0.050 |
Why?
|
Cations | 1 | 2000 | 238 | 0.040 |
Why?
|
Ions | 1 | 2000 | 256 | 0.040 |
Why?
|
Endothelial Cells | 1 | 2013 | 3541 | 0.040 |
Why?
|
Nortropanes | 1 | 1999 | 12 | 0.040 |
Why?
|
Chlorides | 1 | 2002 | 665 | 0.040 |
Why?
|
Biological Transport, Active | 1 | 2000 | 328 | 0.040 |
Why?
|
Benzhydryl Compounds | 1 | 2006 | 916 | 0.040 |
Why?
|
Cannabis | 1 | 2006 | 437 | 0.040 |
Why?
|
Disease Models, Animal | 3 | 2014 | 18216 | 0.040 |
Why?
|
Protein Structure, Secondary | 2 | 1999 | 1230 | 0.040 |
Why?
|
Genotype | 2 | 2010 | 12976 | 0.040 |
Why?
|
Nicotine | 1 | 2004 | 680 | 0.040 |
Why?
|
Lac Operon | 1 | 1999 | 237 | 0.040 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2006 | 1248 | 0.040 |
Why?
|
Tryptophan | 1 | 2000 | 482 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2003 | 1246 | 0.040 |
Why?
|
Risk | 1 | 2010 | 9605 | 0.040 |
Why?
|
Stress, Psychological | 1 | 2014 | 4475 | 0.040 |
Why?
|
Male | 11 | 2014 | 360035 | 0.040 |
Why?
|
Microscopy, Immunoelectron | 1 | 1998 | 317 | 0.040 |
Why?
|
Epigenesis, Genetic | 1 | 2011 | 3782 | 0.040 |
Why?
|
Mice, Inbred C57BL | 2 | 2014 | 22121 | 0.040 |
Why?
|
Corpus Striatum | 3 | 2010 | 1235 | 0.040 |
Why?
|
Case-Control Studies | 2 | 2016 | 22097 | 0.040 |
Why?
|
Rats, Sprague-Dawley | 4 | 2010 | 8163 | 0.040 |
Why?
|
Base Composition | 1 | 1997 | 290 | 0.040 |
Why?
|
Drug Interactions | 1 | 2002 | 1415 | 0.040 |
Why?
|
Sodium | 1 | 2002 | 1589 | 0.040 |
Why?
|
Intracellular Membranes | 1 | 1998 | 389 | 0.040 |
Why?
|
Sequence Analysis, DNA | 2 | 2006 | 4735 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2011 | 5794 | 0.030 |
Why?
|
Transcription, Genetic | 1 | 2010 | 7597 | 0.030 |
Why?
|
Drug Resistance | 1 | 2002 | 1597 | 0.030 |
Why?
|
Female | 12 | 2013 | 391875 | 0.030 |
Why?
|
Risk Factors | 2 | 2013 | 74055 | 0.030 |
Why?
|
Neuropeptides | 1 | 2000 | 944 | 0.030 |
Why?
|
Receptors, Opioid, mu | 1 | 2016 | 167 | 0.030 |
Why?
|
Restriction Mapping | 1 | 1995 | 853 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2010 | 14397 | 0.030 |
Why?
|
Binding Sites | 2 | 2004 | 6042 | 0.030 |
Why?
|
Neuroprotective Agents | 2 | 2011 | 957 | 0.030 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2006 | 3702 | 0.030 |
Why?
|
Genetic Complementation Test | 1 | 1994 | 555 | 0.030 |
Why?
|
Microtomy | 1 | 2013 | 44 | 0.030 |
Why?
|
Nucleotides | 1 | 1995 | 454 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 2 | 2011 | 17854 | 0.030 |
Why?
|
Behavior, Animal | 2 | 2011 | 1877 | 0.030 |
Why?
|
Kinetics | 1 | 2000 | 6377 | 0.030 |
Why?
|
Conserved Sequence | 1 | 1995 | 1164 | 0.020 |
Why?
|
Tissue Culture Techniques | 1 | 2013 | 290 | 0.020 |
Why?
|
Uncoupling Agents | 1 | 2011 | 46 | 0.020 |
Why?
|
Freezing Reaction, Cataleptic | 1 | 2011 | 41 | 0.020 |
Why?
|
Schizophrenia | 1 | 2010 | 6927 | 0.020 |
Why?
|
Cell Membrane | 1 | 2000 | 3685 | 0.020 |
Why?
|
Pentylenetetrazole | 1 | 2010 | 71 | 0.020 |
Why?
|
Apomorphine | 1 | 2010 | 149 | 0.020 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2010 | 127 | 0.020 |
Why?
|
bcl-2-Associated X Protein | 1 | 2011 | 282 | 0.020 |
Why?
|
Carbocyanines | 1 | 2010 | 175 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 1995 | 4174 | 0.020 |
Why?
|
Cell Movement | 2 | 2013 | 5198 | 0.020 |
Why?
|
Intermediate Filament Proteins | 1 | 2010 | 262 | 0.020 |
Why?
|
Lewy Bodies | 1 | 2009 | 145 | 0.020 |
Why?
|
Recombinant Proteins | 2 | 1998 | 6525 | 0.020 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 2010 | 370 | 0.020 |
Why?
|
Mice, Transgenic | 2 | 2013 | 9533 | 0.020 |
Why?
|
Proteins | 1 | 2004 | 6033 | 0.020 |
Why?
|
Electron Transport Complex I | 1 | 2009 | 153 | 0.020 |
Why?
|
Rotation | 1 | 2010 | 517 | 0.020 |
Why?
|
Receptors, GABA-A | 1 | 2013 | 621 | 0.020 |
Why?
|
Substantia Nigra | 1 | 2010 | 350 | 0.020 |
Why?
|
Depressive Disorder, Major | 1 | 2006 | 4760 | 0.020 |
Why?
|
Locomotion | 1 | 2010 | 388 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2011 | 1844 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2013 | 2060 | 0.020 |
Why?
|
Adult | 4 | 2011 | 220781 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2013 | 1674 | 0.020 |
Why?
|
Cell Division | 1 | 1994 | 4461 | 0.020 |
Why?
|
5' Flanking Region | 1 | 2006 | 31 | 0.020 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2013 | 1135 | 0.020 |
Why?
|
Phenethylamines | 1 | 2006 | 95 | 0.020 |
Why?
|
Neurogenesis | 1 | 2013 | 862 | 0.020 |
Why?
|
Pharmacogenetics | 1 | 2010 | 675 | 0.020 |
Why?
|
Drug Design | 2 | 2004 | 1050 | 0.020 |
Why?
|
Receptor, Cannabinoid, CB2 | 1 | 2006 | 48 | 0.020 |
Why?
|
Receptors, Dopamine D3 | 1 | 2006 | 108 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2010 | 1083 | 0.020 |
Why?
|
Neovascularization, Physiologic | 1 | 2013 | 1339 | 0.020 |
Why?
|
Dependovirus | 1 | 2010 | 715 | 0.020 |
Why?
|
Mitosis | 1 | 2010 | 1186 | 0.020 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2006 | 1058 | 0.020 |
Why?
|
Receptor, Cannabinoid, CB1 | 1 | 2006 | 137 | 0.020 |
Why?
|
Serotonin | 1 | 2009 | 1040 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2010 | 18955 | 0.010 |
Why?
|
Catecholamine Plasma Membrane Transport Proteins | 1 | 2004 | 1 | 0.010 |
Why?
|
Models, Biological | 1 | 2000 | 9462 | 0.010 |
Why?
|
Macaca fascicularis | 1 | 2006 | 901 | 0.010 |
Why?
|
Norepinephrine | 1 | 2006 | 897 | 0.010 |
Why?
|
Synaptosomes | 1 | 2003 | 116 | 0.010 |
Why?
|
Basal Ganglia | 1 | 2006 | 554 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2011 | 2137 | 0.010 |
Why?
|
alpha-Synuclein | 1 | 2009 | 750 | 0.010 |
Why?
|
Antioxidants | 1 | 2011 | 1670 | 0.010 |
Why?
|
CHO Cells | 1 | 2006 | 1389 | 0.010 |
Why?
|
Membrane Transport Modulators | 1 | 2002 | 24 | 0.010 |
Why?
|
Cell Differentiation | 2 | 2010 | 11526 | 0.010 |
Why?
|
Receptors, Cannabinoid | 1 | 2002 | 43 | 0.010 |
Why?
|
Cricetinae | 1 | 2006 | 2427 | 0.010 |
Why?
|
Cohort Studies | 1 | 2004 | 41366 | 0.010 |
Why?
|
Xenopus laevis | 1 | 2006 | 963 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2013 | 3609 | 0.010 |
Why?
|
Endocannabinoids | 1 | 2002 | 111 | 0.010 |
Why?
|
Cell Survival | 1 | 2011 | 5790 | 0.010 |
Why?
|
MPTP Poisoning | 1 | 2000 | 37 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2010 | 3392 | 0.010 |
Why?
|
Quinolines | 1 | 2006 | 764 | 0.010 |
Why?
|
Middle Aged | 2 | 2011 | 220382 | 0.010 |
Why?
|
Amphetamines | 1 | 2000 | 143 | 0.010 |
Why?
|
Macaca mulatta | 1 | 2006 | 2322 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2004 | 2265 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2010 | 2895 | 0.010 |
Why?
|
Treatment Outcome | 3 | 2011 | 64591 | 0.010 |
Why?
|
Wakefulness | 1 | 2006 | 1265 | 0.010 |
Why?
|
Aged | 1 | 2011 | 168840 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2011 | 7029 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2010 | 3610 | 0.010 |
Why?
|
Oligopeptides | 1 | 2003 | 1186 | 0.010 |
Why?
|
Protein Transport | 1 | 2003 | 1965 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2003 | 3592 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2006 | 3777 | 0.010 |
Why?
|
Antipsychotic Agents | 1 | 2010 | 3066 | 0.010 |
Why?
|
Molecular Conformation | 1 | 1998 | 545 | 0.010 |
Why?
|
Epilepsy | 1 | 2010 | 3286 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2003 | 3710 | 0.010 |
Why?
|
Genome, Human | 1 | 2006 | 4423 | 0.010 |
Why?
|
Phosphorylation | 1 | 2004 | 8311 | 0.010 |
Why?
|
Phenotype | 1 | 2010 | 16585 | 0.010 |
Why?
|
Peptides | 1 | 2003 | 4338 | 0.010 |
Why?
|
Arrhythmias, Cardiac | 1 | 2000 | 2248 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2006 | 6475 | 0.010 |
Why?
|
Kidney | 1 | 2003 | 7046 | 0.000 |
Why?
|
Membrane Proteins | 1 | 2000 | 7849 | 0.000 |
Why?
|
Aging | 1 | 2000 | 8689 | 0.000 |
Why?
|